Neurovascular Devices Market Global Trends And Revenue Growth Up

Neurovascular Devices Market Summary

The global neurovascular devices market size was estimated at USD 7.34 billion in 2024 and is projected to reach USD 11.91 billion by 2033, growing at a CAGR of 5.48% from 2025 to 2033. The market is driven by the rising prevalence of neurovascular disorders, advancements in medical technology, and an increasing focus on minimally invasive procedures. The growing elderly population and lifestyle-related factors such as hypertension and diabetes further contribute to the increasing risk of neurovascular conditions, thereby supporting market expansion.

As conditions such as stroke, cerebral aneurysms, and Arteriovenous Malformations (AVM) become more common, the demand for effective treatment options also increases. The increasing prevalence of neurovascular diseases such as strokes and aneurysms is a major driving force behind the neurovascular devices industry. Various neurovascular devices, including clot retrieval devices, microcatheters, and flow diversion coils, are utilized to treat these conditions. According to the Global Stroke Fact Sheet 2024 published by the World Stroke Organization (WSO), more than 12 million new strokes occur annually, and about 25% of the global population will experience a stroke in their lifetime. This highlights the urgent need for advanced and efficient neurovascular treatment solutions.

Key Market Trends & Insights

• North America dominated the neurovascular devices market with the largest revenue share of 27.40% in 2024. This dominance is attributed to strong healthcare infrastructure, growing adoption of technologically advanced devices, and higher awareness regarding early disease diagnosis. Moreover, supportive reimbursement policies and the presence of major industry players strengthen the region’s leadership.
• The neurovascular device market in the U.S. is expected to register significant CAGR over the forecast period due to the increasing burden of stroke cases, improvements in clinical outcomes with minimally invasive neuro-interventions, and rapid product launches driven by strong R&D investments.
• By device, the cerebral embolization and aneurysm coiling devices segment led the market with the largest revenue share of 37.56% in 2024. These devices are widely used in treating cerebral aneurysms and preventing hemorrhagic stroke, which continues to boost demand for coiling systems and embolic materials.
• Based on therapeutic application, the cerebral aneurysm segment is anticipated to grow at the fastest CAGR over the forecast period. Growing awareness regarding early detection, coupled with advancements in imaging technologies and endovascular procedures, is supporting this growth trend.
• Based on size, the 0.021" segment led the market with the largest revenue share of 26.99% in 2024. The dominance of this segment is mainly due to its widespread usage across various neurovascular interventions, offering improved navigability and device compatibility.

Order a free sample PDF of the Neurovascular Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 7.34 Billion
• 2033 Projected Market Size: USD 11.91 Billion
• CAGR (2025-2033): 5.48%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Medtronic, Stryker, Johnson & Johnson and its affiliates, Penumbra, Inc., MicroPort Scientific Corporation, Terumo Corporation, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., NeuroSafe Medical Co., Ltd., Rapid Medical, phenox GmbH, Lepu Medical Technology(Beijing) Co., Ltd, Evasc Neurovascular Enterprises, and Acandis GmbH are some of the major players in the neurovascular devices industry. Companies are launching novel products and also focusing on gaining regulatory approvals. Moreover, industry players are also forming distribution partnerships to gain a competitive advantage.

Key Players

• Medtronic
• Stryker
• Johnson & Johnson and its affiliates
• Johnson & Johnson and its affiliates
• MicroPort Scientific Corporation
• Terumo Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
• NeuroSafe Medical Co., Ltd.
• Rapid Medical
• Evasc Neurovascular Enterprises
• Lepu Medical Technology(Beijing)Co., Ltd.
• Acandis GmbH
• phenox GmbH

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The neurovascular devices market continues to gain momentum due to rising cases of stroke and other neurovascular conditions, especially among the aging global population. Increased focus on minimally invasive treatment procedures and continuous technological improvements have enhanced treatment efficiency and patient recovery outcomes. Leading healthcare regions, particularly North America, further support industry growth through improved access to advanced medical facilities and strong reimbursement structures. Key developments in embolization and coiling technologies are transforming neurovascular intervention approaches. Growing investment in R&D and clinical innovations is expected to bring next-generation solutions, ultimately strengthening market opportunities and improving neurological health outcomes in the coming years.